HER2 Support Group Forums - View Single Post - from latest article on CNS mets in her2+ metastatic breast cancer pts on herceptin

Gerri · 10-12-2008, 03:48 PM

Lani,

My understanding, and I could be WAY off, is that the 30% - 40% statistics are for those with metastatic disease. Can you confirm that? And if so, are there stats out there for CNS mets and early stage bc? Should early stagers be getting routine brain MRIs? Would love to know!

As always, thanks for your input.

10-12-2008, 03:48 PM	#5
Gerri Senior Member Join Date: Oct 2006 Location: Southern California Posts: 900	Lani, My understanding, and I could be WAY off, is that the 30% - 40% statistics are for those with metastatic disease. Can you confirm that? And if so, are there stats out there for CNS mets and early stage bc? Should early stagers be getting routine brain MRIs? Would love to know! As always, thanks for your input. __________________ Gerri Dx: 11/23/05, Lumpectomy 12/12/05 Tumor 2.2 cm, Stage II, Grade 3, Sentinel Node biopsy negative ER+ (30%) /PR+ (50%), HER2+++ AC X 4 dose dense, Taxol X 4 dose dense Herceptin started with 2nd Taxol, given weekly until chemo done then given every 3 weeks for one year ending on March 16, 2007 Radiation 30 treatments Tamoxifen - 2 yrs (pre-menopausal) May 2008 - Feb 2012 Femara Aug 2008 - Feb 2012 Zometa every 6 months March 2012 - Stop Femara, now Evista for bone strengthening ********** Enjoy the little things, for one day you may look back and realize they were the big things. - Robert Brault